{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:26:16Z","timestamp":1773465976700,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T00:00:00Z","timestamp":1657411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006559","name":"University of Tsukuba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.conctc.2022.100967","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T23:53:50Z","timestamp":1659657230000},"page":"100967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-1946","authenticated-orcid":false,"given":"Takahiro","family":"Higashibata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-9881","authenticated-orcid":false,"given":"Jun","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaomi","family":"Kessoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kajiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Oyamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumi","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-122X","authenticated-orcid":false,"given":"Toshikazu","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroka","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2022.100967_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)","volume":"10","author":"Bell","year":"2009","journal-title":"Pain Med."},{"key":"10.1016\/j.conctc.2022.100967_bib2","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1002\/cam4.2341","article-title":"Incidence of opioid-induced constipation in Japanese patients with cancer pain: a prospective observational cohort study","volume":"8","author":"Tokoro","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.conctc.2022.100967_bib3","series-title":"Guidelines for the Palliation of Gastrointestinal Symptoms in Cancer Patients","year":"2017"},{"key":"10.1016\/j.conctc.2022.100967_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/AJP.0b013e318237d626","article-title":"A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction","volume":"28","author":"Ishihara","year":"2012","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.conctc.2022.100967_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American gastroenterological association Institute guideline on the medical management of opioid-induced constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.conctc.2022.100967_bib6","series-title":"Committee for the Development of Guidelines for Palliative Medicine, Japanese Society of Palliative Medicine. Guidelines for the Pharmacotherapy of Cancer Pain","year":"2020"},{"key":"10.1016\/j.conctc.2022.100967_bib7","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2017.73.0853","article-title":"Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer","volume":"35","author":"Katakami","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.conctc.2022.100967_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40880-017-0241-4","article-title":"Efficacy and safety of controlled-release oxycodone\/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial","volume":"36","author":"Lee","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.conctc.2022.100967_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3111\/13696990903430481","article-title":"Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation","volume":"12","author":"Rentz","year":"2009","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.conctc.2022.100967_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/147323001103900106","article-title":"The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients","volume":"39","author":"Ueberall","year":"2011","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.conctc.2022.100967_bib11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/annonc\/mdy118","article-title":"Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer","volume":"29","author":"Katakami","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.conctc.2022.100967_bib12","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000230","article-title":"Difference in defecation desire between patients with and without chronic constipation: a large-scale internet survey","volume":"11","author":"Ohkubo","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.conctc.2022.100967_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00535-013-0825-y","article-title":"Validity and reliability of the Japanese version of the patient Assessment of constipation quality of life questionnaire","volume":"49","author":"Nomura","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.conctc.2022.100967_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/00365520510012208","article-title":"Development and validation of the patient Assessment of constipation quality of life questionnaire","volume":"40","author":"Marquis","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.conctc.2022.100967_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.conctc.2022.100967_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2005.06.022","article-title":"The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care","volume":"42","author":"Groenvold","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.conctc.2022.100967_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11136-011-9939-y","article-title":"Verification of the psychometric properties of the Japanese version of the European organization for research and treatment of cancer quality of life questionnaire Core 15 palliative (EORTCQLQ-C15-PAL)","volume":"21","author":"Miyazaki","year":"2012","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.conctc.2022.100967_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jpainsymman.2010.05.009","article-title":"Cross-cultural application of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire-core 15-palliative care","volume":"41","author":"Shin","year":"2011","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.conctc.2022.100967_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/bmj.300.6722.439","article-title":"Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate","volume":"300","author":"O'Donnell","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.conctc.2022.100967_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12876-020-1173-z","article-title":"Prevention and management of diarrhea associated with naldemedine among patients receiving opioids: a retrospective cohort study","volume":"20","author":"Takagi","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.conctc.2022.100967_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/2050640618786145","article-title":"The patient burden of opioid-induced constipation: new insights from a large, multinational survey in five European countries","volume":"6","author":"Andresen","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.conctc.2022.100967_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/104990910201900616","article-title":"Presence and severity of constipation in hospice patients with advanced cancer","volume":"19","author":"McMillan","year":"2002","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.conctc.2022.100967_bib23","first-page":"817","article-title":"How problematic are various aspects of quality of life in patients with cancer at the end of life?","volume":"27","author":"McMillan","year":"2000","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.conctc.2022.100967_bib24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ejp.1054","article-title":"A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160\/80 mg daily) vs oxycodone PR","volume":"21","author":"Dupoiron","year":"2017","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.conctc.2022.100967_bib25","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1185\/03007990802584454","article-title":"Fixed-ratio combination oxycodone\/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain","volume":"24","author":"Simpson","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.conctc.2022.100967_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpain.2008.06.012","article-title":"A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation","volume":"13","author":"Meissner","year":"2009","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.conctc.2022.100967_bib27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1185\/03007995.2015.1047747","article-title":"Safety and efficacy of oxycodone\/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations","volume":"31","author":"Ueberall","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.conctc.2022.100967_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2008.03884.x","article-title":"Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study","volume":"29","author":"Quigley","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.conctc.2022.100967_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2015.115","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation","volume":"110","author":"Yiannakou","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.conctc.2022.100967_bib30","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1200\/JCO.2016.70.8453","article-title":"Phase IIb, randomized, double-blind, placebo-controlled study of naldemedine for the treatment of opioid-induced constipation in patients with cancer","volume":"35","author":"Katakami","year":"2017","journal-title":"J. Clin. Oncol."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865422000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865422000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:05:54Z","timestamp":1762520754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865422000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"alternative-id":["S2451865422000849"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2022.100967","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2022.100967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100967"}}